• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2012 Fiscal Year Final Research Report

Predictive and prognostic significance of tumor-infiltrating lymphocytes in high-grade breast cancer

Research Project

  • PDF
Project/Area Number 22501039
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Tumor diagnosis
Research InstitutionNational Cancer Center Japan

Principal Investigator

TSUDA Hitoshi  独立行政法人国立がん研究センター, 中央病院, 科長 (70217321)

Project Period (FY) 2010 – 2012
Keywords乳癌 / 腫瘍浸潤リンパ球 / 治療効果予測 / 組織型
Research Abstract

The purpose of the present study was to identify histological surrogate predictive markers of pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC). 92 core needle biopsy (CNB) specimens obtained before NAC were available. As controls, CNB specimens from 42 tumors of the hormone receptor-negative and HER2-positive (HR-/HER2+) subtype and 46 tumors of the hormone receptor-positive and HER2-negative (HR+/HER2-) subtype were also included. Histopathological examination including tumor-infiltrating lymphocytes (TIL) and tumor cell apoptosis, and immunohistochemical studies for basal markers were performed, In TNBC, the pCR rate of tumors showing a high TIL score was 37%, and significantly higher than that of the tumors showing a low TIL score (16%, p = 0.05). In a total of 180 breast cancers, the pCR rate of the tumors showing a high TIL score (34%) was significantly higher than that of the tumors showing a low TIL score (10%) (p = 0.0001). In TNBC, the pCR rate of tumors showing an apoptosis score 2 was 48%, and tended to be higher than that of the tumors showing an apoptosis score of 0 or 1 (23%, p = 0.10). In a total of 180 breast cancers, the pCR rate of the tumors showing an apoptosis score 2 (35%) was significantly higher than that of the tumors showing an apoptosis score of 0 or 1 (19%) (p = 0.04). The basal-like marker expression or p53 nuclear immunoreaction was not correlated with pCR in TNBC. Histologically, medullary/atypical medullary and apocrine types showed higher pCR rates (39% and 40%), while central acellular and metaplastic types showed lower pCR rates (21% and 17%). The degree of TIL correlated with immune response appear to play a substantial role in the response to NAC in TNBC.

  • Research Products

    (12 results)

All 2013 2012 2011 2010 Other

All Journal Article (6 results) (of which Peer Reviewed: 6 results) Presentation (6 results)

  • [Journal Article] Prognostic factors for triple- negative breast cancer patients receiving preoperative systemic chemotherapy.2013

    • Author(s)
      Sota Asaga, Takayuki Kinoshita, Takashi Hojo, Junko Suzuki, Kenjiro Jimbo, Hitoshi Tsuda
    • Journal Title

      Clinical Breast Cancer

      Volume: 13巻1号 Pages: 40-46

    • Peer Reviewed
  • [Journal Article] The difference in the histologic types of the breast cancer and the response to primary systemic chemotherapy: clinicopathological characteristics and relation with outcome.2012

    • Author(s)
      Tomoya Nagao, Takayuki Kinoshita, Takashi Hojo, Hitoshi Tsuda, Kenji Tamura, Yasuhiro Fujiwara
    • Journal Title

      Breast

      Volume: 21巻3号 Pages: 289-295

    • Peer Reviewed
  • [Journal Article] Tumor-infiltrating lymphocytes (TIL) are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer.2012

    • Author(s)
      Makiko Ono, Hitoshi Tsuda, Chikako Shimizu, Sohei Yamamoto, Tatsuhiro Shibata, Harukaze Yamamoto, Taizo Hirata, Kan Yonemori, Tsutomu Kouno, Masashi Ando, Kenji Tamura, Noriyuki Katsumata, Takayuki Kinoshita, Yasuhiro Fujiwara
    • Journal Title

      Breast Cancer Research and Treatment

      Volume: 132巻3号 Pages: 793-805

    • Peer Reviewed
  • [Journal Article] Expression pattern of stromal cell-derived factor-1 (SDF-1) chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.2012

    • Author(s)
      Takayuki Kobayashi, Hitoshi Tsuda, Tomoyuki Moriya, Tamio Yamasaki, Ryoko Kikuchi, Shigeto Ueda, Junji Yamamoto, Osamu Matsubara
    • Journal Title

      Breast Cancer Research and Treatment

      Volume: 123巻3号 Pages: 733-745

    • Peer Reviewed
  • [Journal Article] Early reduction in standardized uptake value after one cycle of neoadjuvant chemo- therapy measured by sequential DG PET/CT is an independent predictor of patho- logical response of primary breast cancer.2010

    • Author(s)
      Shigeto Ueda, Hitoshi Tsuda, Toshiaki Saeki, Kazuhiko Fukatsu, Akihiko Osaki, Takashi Shigekawa, Jiro Ishida, Katsumi Tamura, Yoshiyuki Abe, Jiro Omata, Tomoyuki Moriya, Junji Yamamoto
    • Journal Title

      Breast Journal

      Volume: 16巻6号 Pages: 660-662

    • Peer Reviewed
  • [Journal Article] Prognostic impact of Ki-67 labeling indices with three different cut-off values and histological and nuclear grades in hormone-receptor- positive, HER2-negative, node-negative invasive breast cancers.

    • Author(s)
      Makiko Ono, Hitoshi Tsuda, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Masashi Ando, Kenji Tamura, Takayuki Kinoshita, Yasuhiro Fujiwara
    • Journal Title

      Breast Cancer

      Volume: (in press)

    • DOI

      DOI:10.1007/s12282-013-0464-4

    • Peer Reviewed
  • [Presentation] 乳癌紡錘細胞癌の病理学的リスク因子の検討2012

    • Author(s)
      神谷有希子、吉田正行、麻賀創太、神保健二郎、鈴木純子、北條隆、木下貴之、津田均
    • Organizer
      第20回日本乳癌学会学術総会
    • Place of Presentation
      熊本
    • Year and Date
      20120628-30
  • [Presentation] Intrinsic subtype分類の病理学的考え方(Histological significance of intrinsic subtype classification).2012

    • Author(s)
      津田 均
    • Organizer
      第10回日本臨床腫瘍学会学術集会、国内合同シンポジウ
    • Place of Presentation
      大阪
    • Year and Date
      2012-07-26
  • [Presentation] リンパ節転移陰性luminal乳癌の予後について2011

    • Author(s)
      小野麻紀子、津田均、清水千佳子、温泉川真由、米盛勧、安藤正志、田村研治、勝俣範之、木下貴之、藤原康弘
    • Organizer
      19回日本乳癌学会学術総会
    • Place of Presentation
      仙台
    • Year and Date
      20110902-04
  • [Presentation] Long-term prognostic factors of node-negative invasive breast cancer of luminal subtype: A comparison between histological grades and molecular markers including. Ki67 and HER22011

    • Author(s)
      Ono Makiko, Hitoshi Tsuda, Chikako Shimizu, Mayu Yunokawa, Kan Yonemori, Masashi Ando, Kenji Tamura, Noriyuki Katsumata, Takayuki Kinoshita, Yasuhiro Fujiwara
    • Organizer
      第9回日本臨床腫瘍学会学術集会
    • Place of Presentation
      横浜
    • Year and Date
      20110721-23
  • [Presentation] トリプルネガティブ乳癌(TNBC)における病理学的治療効果予測因子2010

    • Author(s)
      小野麻紀子、津田均、清水千佳子、平岡伸介、田村研治、山本春風、米盛勧、安藤正志、勝俣範之、木下貴之、藤原康弘
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪
    • Year and Date
      20100922-24
  • [Presentation] トリプルネガティブ乳癌(TNBC) における病理学的治療効果予測因子:組織亜型と腫瘍浸潤リンパ球(TIL)2010

    • Author(s)
      小野麻紀子、津田均、清水千佳子、平岡伸介、田村研治、山本春風、平田泰三、米盛勧、河野勤、安藤正志、勝俣範之、木下貴之、藤原康弘
    • Organizer
      第18回日本乳癌学会学術総会
    • Place of Presentation
      札幌
    • Year and Date
      20100624-25

URL: 

Published: 2014-08-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi